11/03/2025
RSV - Respiratory Syncytial Virus
Each year in the United States, respiratory syncytial virus (RSV) kills up to 10,000 people, including 100 to 300 children. About 1 or 2 of every 100 children will be hospitalized with a lower respiratory tract infection caused by RSV in the first six months of life. Almost all children get RSV at least once by the time they are 24 months of age.
An injection of RSV monoclonal antibodies in the first 8 months of life can help protect them and make them less likely to require medical care for RSV. In studies, medical care included going to the emergency room, being hospitalized, ending up in the intensive care unit or needing oxygen. Both antibody products are estimated to prevent about 7 or 8 of every 10 babies who receive them from having severe RSV that requires these types of medical care.
Call or text 307.217.6011 to schedule.
To learn more, click here
https://www.chop.edu/vaccine-education-center/vaccine-details/rsv-vaccine-monoclonal-antibody